_id

690da940ccc777a4e85d0839

Ticker

ACRS

Name

Aclaris Therapeutics Inc

Exchange

NASDAQ

Address

701 Lee Road, Wayne, PA, United States, 19087

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.aclaristx.com

Description

Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing therapies to address significant unmet needs for immuno-inflammatory diseases. Its Contract Research segment provides laboratory services. The company also develops ATI-1777, a soft JAK 1/3 inhibitor in Phase 2b trial for the treatment of atopic dermatitis and other dermatologic conditions; Bosakitug (ATI-045), an anti-TSLP monoclonal antibody in Phase 2a trial to treat moderate to severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, and moderate to severe chronic obstructive pulmonary disease; ATI-2138, an oral covalent inhibitor of ITK and JAK3 inhibitor in Phase 2a trial for the treatment for T cell-mediated autoimmune diseases; Zunsemetinib (ATI-450), a mitogen-activated protein kinase-activated protein kinase 2 inhibitor under Phase 1b/2 trials for the treatment of metastatic breast cancer and pancreatic ductal adenocarcinoma; and ATI-052, a humanized anti-TSLP and anti-IL4R bispecific antibody in preclinical stage to treat various atopic, immunologic, and respiratory diseases, as well as an ITK selective inhibitor candidate for the treatment of autoimmune diseases. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Last Close

3.36

Volume

1275947

Current Price

3.25

Change

-3.2738095238095206

Last Updated

2025-11-28T11:49:38.409Z

Image

data:image/webp;base64,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

Ipo Date

2015-10-07T00:00:00.000Z

Market Cap

312034304

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.7583333333333333

Sentiment Sources

3

Rating

4.3333

Target Price

7.6667

Strong Buy

3

Buy

2

Hold

1

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

3299000

Cost Of Revenue

538000

Gross Profit

2761000

Operating Expenses

19910000

Operating Income

-17149000

Interest Expense

-

Pretax Income

-14614000

Net Income

-14614000

Eps

-0.11918187992428045

Dividends Per Share

-

Shares Outstanding

108345239

Income Tax Expense

-

EBITDA

-14404000

Operating Margin

-519.8241891482267

Total Other Income Expense Net

2535000

Cash

25256000

Short Term Investments

70656000

Receivables

4680000

Inventories

-

Total Current Assets

100592000

Property Plant Equipment

3239000

Total Assets

175534000

Payables

9187000

Short Term Debt

533000

Long Term Debt

-

Total Liabilities

55434000

Equity

120100000

Depreciation

210000

Change In Working Capital

612000

Cash From Operations

-10932000

Capital Expenditures

23000

Cash From Investing

13830000

Cash From Financing

-3044000

Net Change In Cash

-146000

PE

-

PB

3.3181745274771024

ROE

-12.16819317235637

ROA

-8.325452618865862

FCF

-10955000

Fcf Percent

-3.320703243407093

Piotroski FScore

1

Health Score

30

Deep Value Investing Score

3

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

4.5

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

3299000

Quarters > 0 > income Statement > cost Of Revenue

538000

Quarters > 0 > income Statement > gross Profit

2761000

Quarters > 0 > income Statement > operating Expenses

19910000

Quarters > 0 > income Statement > operating Income

-17149000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-14614000

Quarters > 0 > income Statement > net Income

-14614000

Quarters > 0 > income Statement > eps

-0.11918187992428045

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

122619311

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-14404000

Quarters > 0 > income Statement > operating Margin

-519.8241891482267

Quarters > 0 > income Statement > total Other Income Expense Net

2535000

Quarters > 0 > balance Sheet > cash

25256000

Quarters > 0 > balance Sheet > short Term Investments

70656000

Quarters > 0 > balance Sheet > receivables

4680000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

100592000

Quarters > 0 > balance Sheet > property Plant Equipment

3239000

Quarters > 0 > balance Sheet > total Assets

175534000

Quarters > 0 > balance Sheet > payables

9187000

Quarters > 0 > balance Sheet > short Term Debt

533000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

55434000

Quarters > 0 > balance Sheet > equity

120100000

Quarters > 0 > cash Flow > net Income

-14614000

Quarters > 0 > cash Flow > depreciation

210000

Quarters > 0 > cash Flow > change In Working Capital

612000

Quarters > 0 > cash Flow > cash From Operations

-10932000

Quarters > 0 > cash Flow > capital Expenditures

23000

Quarters > 0 > cash Flow > cash From Investing

13830000

Quarters > 0 > cash Flow > cash From Financing

-3044000

Quarters > 0 > cash Flow > net Change In Cash

-146000

Quarters > 0 > ratios > PE

-0.11918187992428045

Quarters > 0 > ratios > PB

3.3181745274771024

Quarters > 0 > ratios > ROE

-12.16819317235637

Quarters > 0 > ratios > ROA

-8.325452618865862

Quarters > 0 > ratios > FCF

-10955000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-3.320703243407093

Quarters > 0 > health Score

30

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

1777000

Quarters > 1 > income Statement > cost Of Revenue

1850000

Quarters > 1 > income Statement > gross Profit

-73000

Quarters > 1 > income Statement > operating Expenses

18335000

Quarters > 1 > income Statement > operating Income

-18408000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-15429000

Quarters > 1 > income Statement > net Income

-15429000

Quarters > 1 > income Statement > eps

-0.1258678274254436

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

122580967

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-16794000

Quarters > 1 > income Statement > operating Margin

-1035.9032076533483

Quarters > 1 > income Statement > total Other Income Expense Net

2979000

Quarters > 1 > balance Sheet > cash

25402000

Quarters > 1 > balance Sheet > short Term Investments

74404000

Quarters > 1 > balance Sheet > receivables

194000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

104202000

Quarters > 1 > balance Sheet > property Plant Equipment

868000

Quarters > 1 > balance Sheet > total Assets

189147000

Quarters > 1 > balance Sheet > payables

8797000

Quarters > 1 > balance Sheet > short Term Debt

1030000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

57408000

Quarters > 1 > balance Sheet > equity

131739000

Quarters > 1 > cash Flow > net Income

-15429000

Quarters > 1 > cash Flow > depreciation

114000

Quarters > 1 > cash Flow > change In Working Capital

759000

Quarters > 1 > cash Flow > cash From Operations

-9993000

Quarters > 1 > cash Flow > capital Expenditures

21000

Quarters > 1 > cash Flow > cash From Investing

5047000

Quarters > 1 > cash Flow > cash From Financing

-9000

Quarters > 1 > cash Flow > net Change In Cash

-4955000

Quarters > 1 > ratios > PE

-0.1258678274254436

Quarters > 1 > ratios > PB

3.0240714044436348

Quarters > 1 > ratios > ROE

-11.711793774053241

Quarters > 1 > ratios > ROA

-8.157147615346794

Quarters > 1 > ratios > FCF

-10014000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-5.635340461451885

Quarters > 1 > health Score

30

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

1455000

Quarters > 2 > income Statement > cost Of Revenue

506000

Quarters > 2 > income Statement > gross Profit

949000

Quarters > 2 > income Statement > operating Expenses

19033000

Quarters > 2 > income Statement > operating Income

-18084000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-15085000

Quarters > 2 > income Statement > net Income

-15085000

Quarters > 2 > income Statement > eps

-0.12325322864835134

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

122390303

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-17656000

Quarters > 2 > income Statement > operating Margin

-1242.8865979381444

Quarters > 2 > income Statement > total Other Income Expense Net

2999000

Quarters > 2 > balance Sheet > cash

30357000

Quarters > 2 > balance Sheet > short Term Investments

74957000

Quarters > 2 > balance Sheet > receivables

250000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

108790000

Quarters > 2 > balance Sheet > property Plant Equipment

942000

Quarters > 2 > balance Sheet > total Assets

198094000

Quarters > 2 > balance Sheet > payables

6354000

Quarters > 2 > balance Sheet > short Term Debt

498000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

54028000

Quarters > 2 > balance Sheet > equity

144066000

Quarters > 2 > cash Flow > net Income

-15085000

Quarters > 2 > cash Flow > depreciation

128000

Quarters > 2 > cash Flow > change In Working Capital

-1935000

Quarters > 2 > cash Flow > cash From Operations

-13057000

Quarters > 2 > cash Flow > capital Expenditures

43000

Quarters > 2 > cash Flow > cash From Investing

19119000

Quarters > 2 > cash Flow > cash From Financing

-275000

Quarters > 2 > cash Flow > net Change In Cash

5787000

Quarters > 2 > ratios > PE

-0.12325322864835134

Quarters > 2 > ratios > PB

2.761015678577874

Quarters > 2 > ratios > ROE

-10.470895284105895

Quarters > 2 > ratios > ROA

-7.615071632659243

Quarters > 2 > ratios > FCF

-13100000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-9.003436426116838

Quarters > 2 > health Score

35

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

9211000

Quarters > 3 > income Statement > cost Of Revenue

9301000

Quarters > 3 > income Statement > gross Profit

-90000

Quarters > 3 > income Statement > operating Expenses

99585000

Quarters > 3 > income Statement > operating Income

-99675000

Quarters > 3 > income Statement > interest Expense

4094000

Quarters > 3 > income Statement > pretax Income

-96552000

Quarters > 3 > income Statement > net Income

-96552000

Quarters > 3 > income Statement > eps

-1.0130761445624152

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

95305768

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-13927000

Quarters > 3 > income Statement > operating Margin

-1082.1300618825317

Quarters > 3 > income Statement > total Other Income Expense Net

3123000

Quarters > 3 > balance Sheet > cash

24570000

Quarters > 3 > balance Sheet > short Term Investments

89024000

Quarters > 3 > balance Sheet > receivables

318000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

125951000

Quarters > 3 > balance Sheet > property Plant Equipment

1008000

Quarters > 3 > balance Sheet > total Assets

220327000

Quarters > 3 > balance Sheet > payables

4690000

Quarters > 3 > balance Sheet > short Term Debt

481000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

64773000

Quarters > 3 > balance Sheet > equity

155554000

Quarters > 3 > cash Flow > net Income

-96552000

Quarters > 3 > cash Flow > depreciation

143000

Quarters > 3 > cash Flow > change In Working Capital

-994000

Quarters > 3 > cash Flow > cash From Operations

-8938000

Quarters > 3 > cash Flow > capital Expenditures

35810000

Quarters > 3 > cash Flow > cash From Investing

-88723000

Quarters > 3 > cash Flow > cash From Financing

74580000

Quarters > 3 > cash Flow > net Change In Cash

-23081000

Quarters > 3 > ratios > PE

-1.0130761445624152

Quarters > 3 > ratios > PB

1.991229708011366

Quarters > 3 > ratios > ROE

-62.069763554778405

Quarters > 3 > ratios > ROA

-43.822137096225156

Quarters > 3 > ratios > FCF

-44748000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-4.858104440343068

Quarters > 3 > health Score

35

Valuation > metrics > PE

-0.11918187992428045

Valuation > metrics > PB

3.3181745274771024

Valuation > final Score

46.818254725228975

Valuation > verdict

10.6% Overvalued

Profitability > metrics > ROE

-12.16819317235637

Profitability > metrics > ROA

-14.52799427389852

Profitability > metrics > Net Margin

-4.429827220369809

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.4615653621981682

Risk > metrics > Interest Coverage

-81.66190476190476

Risk > final Score

-267

Risk > verdict

High

Liquidity > metrics > Current Ratio

10.348971193415638

Liquidity > metrics > Quick Ratio

10.348971193415638

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

49.759285955563655

Prev Valuations > 1

80

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

6

Prev Risks > 1

32

Prev Risks > 2

-37

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:11:44.777Z